by Jeggathishwaran Panisilvam  , Peng Cheng Wang  and Hui An

Received: 26 March 2022;  Published: 13 July 2022;  doi: 10.21926/jept.2203024

Reducing and conserving fuel usage is pivotal for any engineering system for the development of a sustainable energy solution. Proton exchange membrane fuel cells (PEMFCs) are one of the promising renewable energy systems that consume hydrogen as their source of fuel to generate electricity. This paper investigate the necessity of the constant supply of fuel (hydrogen) in the PEMFC system to ensure stable operation. We propose that a dynamic supply of fuel could help achieve similar performance and reduce the amoun [...]

by Rebecca L. Utz  , Michael Caserta  , Eli Iacob  , Catharine Sparks  , Louisa Stark  , Alexandra Terrill  , Amber Thompson  and Bob Wong

Received: 15 June 2023;  Published: 08 October 2023;  doi: 10.21926/obm.icm.2304040

Dementia caregivers are susceptible to adverse physical and mental health outcomes, given the often prolonged and challenging care and support they provide to family members with Alzheimer’s Disease and Related Dementias (ADRD). This report describes a community-engaged implementation of a novel behavioral intervention - an “app” (interactive website) called TLC (Time for Living and Caring) that coaches caregivers on how to maximize the benefits associated with respite time. The rationale and features of the TLC in [...]

by Lara T. C. Mota  , Igor M. Figueredo  , F. Murilo T. Luna  , Rodrigo S. Vieira  , Célio L. Cavalcante Jr.  and M. Alexsandra S. Rios

Received: 26 September 2022;  Published: 22 December 2022;  doi: 10.21926/jept.2204042

In this study, the oxidative stability of the cottonseed oil biodiesel (CB) and soybean oil biodiesel (SB) was investigated by two methodologies, Rancimat and Differential Scanning Calorimetry (DSC), using samples fresh and aged (mid-term storage condition (100 days)). The biodiesel samples were synthesized by transesterification and characterized by specific mass, kinematic viscosity, acidity value, ester content, viscosity index, and peroxide value. The activation energy (Ea), Arrhenius pre-exponential factor (Z) [...]

by Louise O’Hare  and Robyn Griffiths

Received: 08 August 2022;  Published: 14 November 2022;  doi: 10.21926/obm.neurobiol.2204145

Although being one of the most common neurological disorders, migraine is commonly misunderstood and misdiagnosed. Current treatments rely on pharmacological approaches, which have been shown not to be effective for all, and so alternative, non-invasive treatments are being sought. Transcranial stimulation could be a possible treatment for migraine. Transcranial electrical stimulation generally involves applying a current to the cortex via the scalp. Whilst this has previously been mostly done in clinical settings, [...]

by Vanessa G. Oliveira  , Ana Filipa Saraiva  , Fátima Costa  and Aida Botelho de Sousa

Received: 27 February 2019;  Published: 24 September 2019;  doi: 10.21926/obm.transplant.1903086

Nowadays, hematopoietic stem cell transplantation (HSCT) is a common procedure in hematology units within reference centers, mainly for the treatment of hematological malignancies such as multiple myeloma, lymphoma, and acute leukemia. Nevertheless, HSCT has much wider applications, namely in autoimmune diseases, congenital metabolic defects, and hemoglobinopathies. Thalassemia major and sickle cell disease make up the most frequent hereditary hemoglobinopathies worldwide. Despite advances on the prevention and tre [...]

by Mauro Turrin  , Lucia Fornasiero  and Antonio Navarro

Received: 08 January 2023;  Published: 27 June 2023;  doi: 10.21926/obm.geriatr.2302240

We describe the clinical case of a 74-year-old male patient who received the second Comirnaty/Pfizer anti-COVID-19 vaccine dose. After 3 weeks he showed the clinical signs of polymyalgia rheumatica. The history included mild chronic normocytic normochromic anemia and hypogammaglobulinemia, osteoarthritis disease, livedo reticularis, hypercholesterolemia, and arterial hypertension. Despite prolonged treatment with NSAIDs and dexamethasone, the disease evolved into remitting seronegative symmetrical synovitis with pi [...]

by Christine M. Bojanowski  , Ian Britton  and Kamyar Afshar

Received: 18 April 2018;  Published: 16 July 2018;  doi: 10.21926/obm.transplant.1803015

Here we present a case of a lung transplant recipient with alpha 1-antitrypsin deficiency as well as conducted a retrospective review of the United Network for Organ Sharing (UNOS) database from 1990 – 2016 specifically grouping patients with alpha-1 antitrypsin deficiency (A1ATD) and chronic obstructive pulmonary disease (COPD).

by Javier Carbone  , Juan Fernandez-Yañez  , Iago Sousa  , Patricia Muñoz  and Elizabeth Sarmiento

Received: 23 November 2018;  Published: 22 March 2019;  doi: 10.21926/obm.transplant.1901058

Secondary antibody deficiency has been associated with risk of invasive fungal infections in solid organ transplantation. Single center, multi-center and meta-analysis studies have tested this association. Therapy of these infectious complications in the presence of a secondary antibody deficiency after transplantation remain a challenge for transplant teams. Currently, there are no guidelines for the management of this combined clinical scenario. We report the case of a patient with severe secondary immunodeficien [...]

by Simona Bassoli  , Anett Schallmey  , Julie Oble  , Giovanni Poli  and Alexandre Pradal

Received: 22 July 2022;  Published: 26 October 2022;  doi: 10.21926/cr.2204036

A two-step protocol for the synthesis of aryl-3-hydroxypropanones, which were regarded as lignin degradation products, was proposed herein. This protocol provided a more rapid and easier access to aryl-3-hydroxypropanones, and aryl-3-hydroxypropanones were expected to be ideal platform molecules for the synthesis of more complex value-added targets.

by Shaymaa Azawi  , Lisa-Marie Barf  , Thomas Liehr  , Stefanie Kankel  and Martina Rincic

Received: 25 March 2022;  Published: 27 June 2022;  doi: 10.21926/obm.genet.2202159

After being established in 1967, the commercially available murine Leydig cell tumor line I-10 has been used in almost 50 published studies. I-10 has not been characterized, either at the chromosomal/ cytogenetic level or the genetic level, similar to many other murine tumor cell lines. In this study, we performed molecular karyotyping and multicolor banding-based molecular cytogenetics. A slightly hyperdiploid karyotype with 43 chromosomes was described. The main aberrations comprised several unbalanced translocat [...]